Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy.

Hisamitsu IshiharaMotonobu AnaiHiroaki SeinoToru KitazawaHiroshi OhashiMasumi AiMasahiro InoueMidori FujishiroTakeshi InazawaHisamoto KurodaMasayo Yamada

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)

Kowa Co. Ltd. and Kowa Pharmaceutical Co. Ltd., Tokyo, Japan.

Keyphrases

type diabetes
adipose tissue
cardiovascular disease
stem cells
bone marrow